MIT Biotechnology Group

MBG Fall Drug Development Seminar Series, Wednesdays, Weekly at 4:30 pm

Logo

Thank you for joining us for our 2018 MBG Fall Drug Development Seminar Series. We enjoyed exploring the process and latest developments in drug development with you as presented by experts across a variety of leading companies in the Cambridge Biotech scene. We look forward to having you join us again in Fall 2019! In the meantime, join us at our many other events in our 2019 lineup as advertised in our weekly digest.


 The Biotechnology Edge
Insights from scientists and biotech leaders on the journey from lab bench to market

Hear from companies across the biotechnology arena, including Novartis, Amgen, Nimbus Therapeutics, Foundation Medicine, and The Boston Consulting Group

Learn about:
– identifying a possible therapeutic target and its role in disease
– increasing therapeutic efficacy and safety
– process development and manufacturing
– intellectual property, business development, and regulatory strategy
– case studies from bench to clinic

4:30 – 5:30 pm, Wednesdays weekly starting 9/19
Refreshments will be provided

  • 9/19 – Phenotypic Drug Discovery
  • 9/26 – Pharmacometrics in Drug Development
  • 10/3 – Development & Characterization of Pre-clinical Cancer Models
  • 10/10 – Pharmacokinetics & Drug Metabolism in Preclinical Drug Discovery and Development
  • 10/17 – Preclinical Development – Safety, Efficacy, and Genetics
  • 10/24 – Case Study – Therapeutic Development from Inception to Late Stage Clinical
  • 10/31 – Manufacturing and Scale-up (Biologics)
  • 11/7 – Clinical Trials, Phases, & NDAs
  • 11/14 – Intellectual Property & IP Strategy
  • 11/28 – Funding & Business Development
  • 12/5 – Regulatory Strategy
  • 12/12 – Medical Devices

Leave a Reply